TIR10Tirzepatide
Dual GLP-1 / GIP agonist · metabolic & weight research
Tirzepatide (Mounjaro®) is a dual GIP and GLP-1 receptor agonist. Phase 3 SURMOUNT trials demonstrated industry-leading weight loss outcomes alongside significant metabolic improvements.
For research use only. Not for human consumption.
Volume pricingper vial
| 1 vial | €39.90 |
| 10+ vials | — |
| 50+ vials | — |
| 100+ vials | — |
For laboratory research use only. Not for human or veterinary consumption.
COA / lab tests
View all →- Tirzepatide 60 mg — ERP batchJanoshik
- Tirzepatide 30 mg — ERP batchJanoshik
- Tirzepatide 15 mg — ERP batchJanoshik
Order
Quantity (vials)
Tier price applies based on total vial count. For laboratory research use only.
